Quantcast

Latest bladder cancer Stories

2014-04-14 23:08:01

A recent published review of the link between Actos and bladder cancer suggests that a federal jury’s judgment against the drug’s manufacturer is justified. Raleigh, NC (PRWEB) April 14, 2014 Earlier this week, a jury awarded $9 billion in punitive damages to a man who says he got bladder cancer from taking the diabetes drug Actos. (Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No. 6:12-cv-00064) According to cancer information site Cancer Monthly,...

2014-04-14 12:34:02

LOS ANGELES, April 14, 2014 /PRNewswire/ -- A highly-specialized urine test can detect bladder cancer as much as three to six months earlier than an invasive cystoscopy procedure, and yet many patients at risk for this disease do not know about it. That's according to specialists at Skyline Urology who are urging individuals at risk for bladder cancer to undergo the urine FISH (fluorescence in situ hybridization) test. The simple test requires a urine sample and involves the...

2014-04-13 23:01:22

Days after a federal jury announced a $9 billion dollar judgment against the drug’s manufacturers, Cancer Monthly is encouraging bladder cancer patients to know their rights. Raleigh, NC (PRWEB) April 13, 2014 The Japanese manufacturer of the diabetes drug Actos and its partner firm, Eli Lilly & Co., have been ordered to pay $9 billion to Terrence Allen, who was diagnosed with bladder cancer after taking Actos. (Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc.,...

2014-04-12 23:01:34

A Louisiana jury’s decision to award $9 billion in damages to a man who says his bladder cancer was caused by the drug Actos could pave a new legal path for other bladder cancer patients. Raleigh, NC (PRWEB) April 12, 2014 Bladder cancer patients who took the drug Actos to control diabetes may now be able to establish a legal nexus or connection between the drug and the disease, thanks to a high-profile legal decision made this week.* If you are a bladder cancer patient who took Actos,...

2014-04-12 23:01:18

The Firm is evaluating Actos lawsuits on behalf of individuals who allegedly developed bladder cancer due to long-term use of Actos. New York, New York (PRWEB) April 12, 2014 Actos lawsuits (http://www.theactoslawsuitcenter.com/) alleging that long-term use of the Type 2 diabetes drug caused patients to develop bladder cancer continue to move forward in federal and state courts throughout the country, Bernstein Liebhard LLP reports. According to court documents, the Nevada Circuit Court...

2014-04-11 08:24:36

SAN DIEGO, April 11, 2014 /PRNewswire/ -- GenomeDx Biosciences announced today that two study abstracts for the company's genomic tests for prostate and bladder cancers have been selected as "Best Posters in a Poster Session" by conference organizers at the 29(th) Annual European Association of Urology Congress. The first poster presentation demonstrates the clinical validation of the Decipher® prostate cancer classifier for predicting treatment failure in men treated with...

2014-04-09 23:25:06

Biochemical testing suggests a pair of proteins can find and monitor bladder cancer better than standard techniques. Raleigh, NC (PRWEB) April 09, 2014 A team of Egyptian biochemists say angiogenin and clusterin – two proteins vital to certain cellular processes – could make bladder cancer diagnosis more accurate and treatments more effective. Click here to read details on the study which has just been posted on the Cancer Monthly website. Researchers with the Faculty of...

2014-04-08 23:02:42

The Firm is filing Actos lawsuits on behalf of individuals who took Actos for an extended period of time and allegedly developed bladder cancer due to their use of the Type 2 diabetes medication. New York, NY (PRWEB) April 08, 2014 The first federal trial of an Actos bladder cancer lawsuit (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) has ended in a significant victory for the Plaintiff, Bernstein Liebhard LLP reports. According to court documents, the jury hearing the...

2014-04-08 23:01:24

Takeda Pharmaceuticals and marketing partner Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages for allegedly withholding information about the potential risks associated with the diabetes drug Actos. Flood Law Group says it agrees with the decision and is available to investigate potential Actos bladder cancer lawsuits. Washington, D.C. (PRWEB) April 08, 2014 A U.S. jury ordered Takeda Pharmaceuticals and marketing partner Eli Lilly & Co. to pay a total...

2014-04-08 23:00:54

Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks. Parker Waichman LLP continues to evaluate cases of bladder cancer in patients who allege serious injuries associated with Actos. New York, New York (PRWEB) April 08, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related